Johnson & Johnson (JNJ) Shareholder Amp Capital Investors LTD Has Lifted Position

September 17, 2017 - By Kurt Siggers

Investors sentiment increased to 0.94 in Q4 2016. Its up 0.12, from 0.82 in 2016Q3. It increased, as 63 investors sold JNJ shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. S&T Bankshares Pa owns 2,898 shares for 0.05% of their portfolio. Dubuque Natl Bank Tru reported 38,344 shares. Adirondack Research And Inc invested in 0.08% or 2,010 shares. Ahl Prtn Llp holds 0.06% or 17,453 shares. 10 holds 3.49% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 107,860 shares. Forester Cap Mngmt Ltd invested in 4.17% or 34,764 shares. Nbt Bancorporation N A has 3.07% invested in Johnson & Johnson (NYSE:JNJ). Patriot Wealth Mgmt stated it has 91,576 shares or 1.99% of all its holdings. Bancshares Of The West has 0.55% invested in Johnson & Johnson (NYSE:JNJ). The North Carolina-based Salem Investment Counselors has invested 2.29% in Johnson & Johnson (NYSE:JNJ). 3,819 are owned by Peregrine Asset Advisers. Adirondack Company invested in 37,588 shares. Barbara Oil stated it has 102,000 shares. First Long Island Invsts Limited Company holds 1.87% or 93,064 shares. Moreover, Susquehanna Interest Ltd Liability Partnership has 0.02% invested in Johnson & Johnson (NYSE:JNJ) for 307,799 shares.

Amp Capital Investors Ltd increased its stake in Johnson & Johnson (JNJ) by 5.43% based on its latest 2016Q4 regulatory filing with the SEC. Amp Capital Investors Ltd bought 62,130 shares as the company’s stock rose 6.85% with the market. The institutional investor held 1.21M shares of the major pharmaceuticals company at the end of 2016Q4, valued at $139.22M, up from 1.14M at the end of the previous reported quarter. Amp Capital Investors Ltd who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $360.86 billion market cap company. The stock increased 0.20% or $0.27 on September 15, reaching $134.45. About 15.52M shares traded or 199.04% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since September 17, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Amp Capital Investors Ltd, which manages about $16.52B US Long portfolio, decreased its stake in Udr Inc (NYSE:UDR) by 351,555 shares to 3.48M shares, valued at $124.71 million in 2016Q4, according to the filing. It also reduced its holding in Mckesson Corp (NYSE:MCK) by 35,052 shares in the quarter, leaving it with 149,255 shares, and cut its stake in Ishares Tr (TIP).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: which released: “Johnson & Johnson’s New Focus” on September 08, 2017, also with their article: “Achillion Is Crushed As Johnson & Johnson Heads For The Exit” published on September 14, 2017, published: “Johnson & Johnson Is Getting Ready for Another Upside Breakout” on September 15, 2017. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: and their article: “Johnson & Johnson says its drug shouldn’t be used in executions” published on August 22, 2017 as well as‘s news article titled: “Achillion Pharmaceuticals falls 25% after hepatitis C deal with J&J unit ends” with publication date: September 11, 2017.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 22 analysts covering Johnson & Johnson (NYSE:JNJ), 10 have Buy rating, 4 Sell and 8 Hold. Therefore 45% are positive. Johnson & Johnson has $14800 highest and $90 lowest target. $128.74’s average target is -4.25% below currents $134.45 stock price. Johnson & Johnson had 64 analyst reports since August 7, 2015 according to SRatingsIntel. The company was upgraded on Tuesday, September 29 by Deutsche Bank. The stock of Johnson & Johnson (NYSE:JNJ) earned “Equal-Weight” rating by Barclays Capital on Tuesday, November 29. BMO Capital Markets maintained Johnson & Johnson (NYSE:JNJ) on Tuesday, July 18 with “Buy” rating. The stock has “Hold” rating by Societe Generale on Wednesday, April 6. The stock of Johnson & Johnson (NYSE:JNJ) has “Hold” rating given on Tuesday, March 15 by Jefferies. The rating was downgraded by Wells Fargo to “Market Perform” on Thursday, January 26. On Monday, July 10 the stock rating was maintained by BMO Capital Markets with “Buy”. The firm has “Outperform” rating given on Tuesday, August 25 by Cowen & Co. Piper Jaffray maintained the stock with “Hold” rating in Tuesday, July 18 report. The firm has “Buy” rating given on Monday, July 10 by RBC Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: